The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Merck
Clinical outcomes following definitive treatment of young-onset, locally advanced rectal cancer: A single institution experience.
 
Nicolette Taku
Research Funding - Varian Medical Systems
 
Y. Nancy You
No Relationships to Disclose
 
Ethan B. Ludmir
No Relationships to Disclose
 
Grace L. Smith
Research Funding - Varian Medical Systems (I)
Other Relationship - Oncora Medical (I)
 
Miguel A. Rodriguez-Bigas
No Relationships to Disclose
 
George J. Chang
Consulting or Advisory Role - 11 Health; Johnson & Johnson; Medicaroid; MORE Health
Research Funding - Agendia
 
John Michael Skibber
No Relationships to Disclose
 
Albert C. Koong
Stock and Other Ownership Interests - Aravive
 
Bruce D. Minsky
No Relationships to Disclose
 
Emma Brey Holliday
No Relationships to Disclose
 
Eugene Jon Koay
Consulting or Advisory Role - Augmenix; RenovoRx
Speakers' Bureau - Oncology Information Group
Research Funding - Elekta; GE Healthcare; Philips Healthcare
Patents, Royalties, Other Intellectual Property - Provisional patent on 3D printed oral stents for radiation treatments of head and neck cancer; Royalties from Taylor and Francis LLC for my co-authored book: An introduction to physical oncology
 
Arvind Dasari
Consulting or Advisory Role - Advanced Accelerator Applications; Hutchison MediPharma; Ipsen; Lexicon; Novartis; Voluntis
Research Funding - Eisai; Guardant Health; Hutchison MediPharma; Ipsen; Merck; Novartis
 
Cullen M. Taniguchi
Honoraria - Xerient
Consulting or Advisory Role - Accuray
Patents, Royalties, Other Intellectual Property - Oral amifostine for radio protection of the intestinal tract; PHD inhibitors for radio protection of the GI Tract
 
Brian K. Bednarski
No Relationships to Disclose
 
Van K. Morris
Honoraria - Projects in Knowledge
Consulting or Advisory Role - Array Biopharma; Axiom Healthcare Strategies; Bicara Therapeutics; BioMedical Insights; Boehringer Ingelheim; Incyte; SERVIER
Research Funding - BioNTech (Inst); Boehringer Ingelheim; Bristol-Myers Squibb (Inst); EMD Serono (Inst); Immatics; Pfizer (Inst)
 
Michael J. Overman
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Gritstone Bio; Janssen; Janssen; MedImmune; Novartis; Pfizer; Pfizer; Promega; Roche/Genentech; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche
 
Scott Kopetz
Stock and Other Ownership Interests - Lutris; MolecularMatch; Navire
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bayer Health; Boehringer Ingelheim; Boston Biomedical; Daiichi Sankyo; EMD Serono; EMD Serono; Genentech; GlaxoSmithKline; HalioDx; Holy Stone Healthcare; Inivata; Ipsen; Jacobio; Jazz Pharmaceuticals; Lilly; Lutris; Merck; Natera; Navire; Novartis; Pfizer; Pierre Fabre; Redx Pharma; Repare Therapeutics; Roche; Symphogen
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); Lilly (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst)
 
Kanwal Pratap Singh Raghav
Consulting or Advisory Role - AstraZeneca; Bayer; Daiichi Sankyo; Eisai
 
Prajnan Das
Consulting or Advisory Role - Adlai Nortye; MD Anderson Cancer Center